142P Updated results from a phase I, open-label, multicenter, first-in-human study of AMG 404, a checkpoint inhibitor, in patients with advanced solid tumors
Title:
142P Updated results from a phase I, open-label, multicenter, first-in-human study of AMG 404, a checkpoint inhibitor, in patients with advanced solid tumors
Author:
Price, T.J. Prenen, H. Lugowska, I. Falchook, G.S. Monzon, J.G. Arkenau, H.T. Chawla, S.P. Hui, M.N. Kuboki, Y. Dziadziuszko, R. Ozawa, Y. Elez Fernandez, M.E. Rocha Lima, C.S.P. Subbiah, V. Tan, D.S.W. Wang, K. Hindoyan, A. Shi, W. Kistler, M. Hashemi Sadraei, N.